IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
09.08.2021
Waltham, MA – September 8, 2021 – Snapdragon Chemistry is pleased to announce chemical engineering Professor Donna Blackmond has joined our Scientific Advisory Board. Known for her pioneering development of Reaction Progress Kinetic Analysis (RPKA), theoretical and experimental studies on the origin of biological homochirality, and many other distinguished accolades, Professor Blackmond is an elected member of the National Academy of Sciences, the National Academy of Engineering, the American Academy of Arts and Sciences, a fellow of the Royal Society of Chemistry and in 2019 received the International Union of Pure and Applied Chemistry Award for Distinguished Women in Chemistry or Chemical Engineering.
“Donna is an extremely influential and accomplished engineer who has made major contributions to our understanding of industrially important chemical processes,” said Snapdragon President/CEO Matthew Bio. “With our focus at Snapdragon on chemical technology, we are thrilled to have Donna advising us as we seek to address challenging problems in chemical manufacturing. Her expertise will be vital to continuing the cutting-edge work we do here at Snapdragon.”
Professor Blackmond is currently the John C. Martin Endowed Chair in Chemistry at the renowned Scripps Research Institute in California, where she has worked since 2010. Her most recent research involves the synthesis of complex molecules by catalytic routes.
Before joining Scripps, Professor Blackmond served as the chair in catalysis at Imperial College in London. She has also held professorships at the University of Hull (United Kingdom), Max-Planck-Institue für Kohlenforschung, and the University of Pittsburgh. In the 1990’s she worked as associate director of technical operations at Merck, where she led efforts in process understanding for the development of anti-HIV treatments known as protease inhibitors.
“Donna has been a key driving force to foster close collaboration between chemists and chemical engineers in the last 30 years. She has influenced a generation of synthetic chemists to view their chemistry and catalysis from the lens of first principles instead of empirical extrapolation,” said Snapdragon Chief Scientific Officer Eric Fang. “Snapdragon’s tremendous growth and success have been greatly attributed to the idea of close collaboration between scientists and engineers. We greatly look forward to her expertise, guidance, and insights as Snapdragon enters next phase of growth.”
Professor Blackmond has been recognized throughout her career with numerous honors including the Max-Planck Award for Outstanding Women Scientists and election to the National Academy of Engineering and the German National Academy of Sciences Leopoldina.
She earned her doctorate in chemical engineering from Carnegie Mellon University in 1984 and began her career at the University of Pittsburgh as a chemical engineer.
“Whether in the lab, classroom, or company headquarters, I’ve always been driven by the way chemistry can help us solve some of the biggest challenges facing our world,” said Blackmond. “Snapdragon has shown it’s on the forefront of this work. I’m grateful to be part of the Scientific Advisory Board and excited to help Snapdragon continue to grow and innovate.”
About Snapdragon Chemistry Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff. For more information, please contact info@snapdragonchemistry.com.